Similarly, in metabolic diseases, such as nonalcoholic fatty liver disease, STAT3 has been implicated in immune cell infiltration and inflammatory regulation through modulation of the GCSFR-SOCS3-JAK-STAT3 signaling pathway [40]. Here, STAT3 is linked to metabolic dysfunction-associated steatotic liver disease.